These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Role of Imbalance between Th17 Cells and Treg Cells in the Pathogenesis of Children with Henoch-Schonlein Purpura]. Wang Q, Shi YY, Cao M, Dong W, Zhang JB. Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Oct; 23(5):1391-6. PubMed ID: 26524044 [Abstract] [Full Text] [Related]
3. Increased serum interleukin-17 and peripheral Th17 cells in children with acute Henoch-Schönlein purpura. Jen HY, Chuang YH, Lin SC, Chiang BL, Yang YH. Pediatr Allergy Immunol; 2011 Dec; 22(8):862-8. PubMed ID: 21929599 [Abstract] [Full Text] [Related]
4. Effects of hemoperfusion in the treatment of childhood Henoch-Schönlein purpura nephritis. Chen L, Wang Z, Zhai S, Zhang H, Lu J, Chen X. Int J Artif Organs; 2013 Jul; 36(7):489-97. PubMed ID: 23661557 [Abstract] [Full Text] [Related]
5. [Clinical effect and mechanism of hemoperfusion in treatment of children with severe abdominal Henoch-Schönlein purpura]. Zhu Y, Dong Y, Xu DL, Jiang JY, Wu L, Ke RJ, Fang SH, Peng Y. Zhongguo Dang Dai Er Ke Za Zhi; 2018 May; 20(5):378-382. PubMed ID: 29764574 [Abstract] [Full Text] [Related]
6. [Levels of IL-12 produced by dendritic cells and changes of TH1/TH2 balance in children with Henoch-Schonlein purpura]. Sun DQ, Zhang QY, Dong ZY, Bai F. Zhongguo Dang Dai Er Ke Za Zhi; 2006 Aug; 8(4):307-10. PubMed ID: 16923364 [Abstract] [Full Text] [Related]
7. Analysis on kidney injury-related clinical risk factors and evaluation on the therapeutic effects of hemoperfusion in children with Henoch-Schonlein purpura. Ma DQ, Li Y, Han ZG, Zheng M, Xu N, Fan XJ. Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3894-3899. PubMed ID: 28975974 [Abstract] [Full Text] [Related]
8. [Serum levels of IL-5 and LTB4 in children with Henoch-Schonlein purpura]. Liao PY, Wu SH. Zhongguo Dang Dai Er Ke Za Zhi; 2006 Jun; 8(3):198-200. PubMed ID: 16787590 [Abstract] [Full Text] [Related]
9. Changes of inflammatory mediators and oxidative stress indicators in children with Henoch-Schönlein purpura and clinical effects of hemoperfusion in the treatment of severe Henoch-Schönlein purpura with gastrointestinal involvement in children. Zhu Y, Dong Y, Wu L, Deng F. BMC Pediatr; 2019 Nov 04; 19(1):409. PubMed ID: 31684904 [Abstract] [Full Text] [Related]
10. [Clinical significance of serum levels of IGF-1 and IGFBP-3 in children with Henoch-Schonlein purpura or Henoch-Schonlein purpura nephritis]. Ru L, Abudouhaer A, Guo YF. Zhongguo Dang Dai Er Ke Za Zhi; 2013 Nov 04; 15(11):1009-13. PubMed ID: 24229600 [Abstract] [Full Text] [Related]
11. [Roles of serum and urinary interleukins 13Ralpha2 and other cytokines in pediatric Henoch-Schonlein purpura]. Yu YH, Pan KL, Li Q, Zhang BJ, Huang Y, Zhang JJ, DU L. Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jan 04; 11(1):37-40. PubMed ID: 19149920 [Abstract] [Full Text] [Related]
12. [IL-33 and sST2 levels in Serum of Children with Henoch-Schnlein Purpura and Their Clinical Significance]. Wang F, Dong LL. Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Apr 04; 25(2):517-521. PubMed ID: 28446304 [Abstract] [Full Text] [Related]
13. [Impact of sera from children with active Henoch-Schönlein purpura on human umbilical venous endothelial cells (HUVECs) and protective effects of methylprednisolone against HUVECs injury]. Wu L, Yuan LP, Fei WJ, Deng F, Zhang Q, Hu B, Lu L. Zhongguo Dang Dai Er Ke Za Zhi; 2012 Jan 04; 14(1):59-63. PubMed ID: 22289755 [Abstract] [Full Text] [Related]
14. Elevated serum interleukin-33 levels in patients with Henoch-Schönlein purpura. Chen T, Jia RZ, Guo ZP, Cao N, Li MM, Jiao XY. Arch Dermatol Res; 2013 Mar 04; 305(2):173-7. PubMed ID: 22836779 [Abstract] [Full Text] [Related]
15. Clinical significance of the serum biomarker index detection in children with Henoch-Schonlein purpura. Purevdorj N, Mu Y, Gu Y, Zheng F, Wang R, Yu J, Sun X. Clin Biochem; 2018 Feb 04; 52():167-170. PubMed ID: 29129626 [Abstract] [Full Text] [Related]
16. [Expression and clinical significance of serum high-mobility group protein box 1 in children with Henoch-Schönlein purpura]. Wang FY, Jiang XM, Lu M. Zhongguo Dang Dai Er Ke Za Zhi; 2015 Aug 04; 17(8):792-5. PubMed ID: 26287340 [Abstract] [Full Text] [Related]
17. Elevated antilysosomal-associated membrane protein-2 antibody levels in patients with adult Henoch-Schönlein purpura. Kawakami T, Takeuchi S, Arimura Y, Soma Y. Br J Dermatol; 2012 Jun 04; 166(6):1206-12. PubMed ID: 22309950 [Abstract] [Full Text] [Related]
18. An analysis of the levels of the soluble form of the endothelial protein C receptor in children with Henoch-Schönlein Purpura. Cayci FS, Ekim M, Egin Y, Gökce H, Yalcinkaya F, Ozcakar B, Akar N. Pediatr Hematol Oncol; 2015 Mar 04; 32(2):115-22. PubMed ID: 24308805 [Abstract] [Full Text] [Related]
19. Investigation of the change in CD4⁺ T cell subset in children with Henoch-Schonlein purpura. Li YY, Li CR, Wang GB, Yang J, Zu Y. Rheumatol Int; 2012 Dec 04; 32(12):3785-92. PubMed ID: 22187057 [Abstract] [Full Text] [Related]
20. Thrombopoietin and interleukin-6 levels in Henoch-Schönlein purpura. Lin CY, Yang YH, Lee CC, Huang CL, Wang LC, Chiang BL. J Microbiol Immunol Infect; 2006 Dec 04; 39(6):476-82. PubMed ID: 17164950 [Abstract] [Full Text] [Related] Page: [Next] [New Search]